Skip to content

Dialectical Moxibustion Treatment of Uremia Patients on Hemodialysis With Frailty Syndrome

Dialectical Moxibustion Treatment of Uremia Patients on Hemodialysis With Frailty Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013931
Enrollment
Unknown
Registered
2017-12-14
Start date
2018-01-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty Syndrome of Hemodialysis Patients

Interventions

test group:dialectical moxibustion
Control group:L-carnitine injection

Sponsors

Wang Jing Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) With regular hemodialysis = 3 months; (2) To meet the diagnostic criteria of frailty syndrome; (3) To meet the diagnostic criteria of TCM syndrome; (4) Consciousness, no history of mental illness or personality disorder; (5) To understand the survey content; (6) Good compliance with Chinese and Western medical treatment orders; (7) To sign informed consent; (8) Aged from 18 to 80 years old.

Exclusion criteria

Exclusion criteria: (1) With regular hemodialysis less than 3 months; (2) Combined with severe cardiovascular and cerebrovascular diseases, infections, malignant tumors, gastrointestinal and liver diseases, fractures; (3) Allergic to L-carnitine, or with history of epilepsy; (4) Have history of skin allergies, or have infected stoves in acupoints, or have diabetes with blood glucose control not up to standard; (5) Poor compliance with Chinese and Western medical treatment orders; (6) Do not cooperate or sign informed consent.

Design outcomes

Primary

MeasureTime frame
evaluation index of frailty syndrome;

Secondary

MeasureTime frame
quality of life;efficacy of TCM syndrome;

Countries

China

Contacts

Public ContactQiu Mo-tan
13601382665@163.com+86 13601382665

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026